Chris Spivey

Chris Spivey is the editorial director of BioPharm International.


Industry’s Best Secret

One can only learn the secrets of "fight club" by attending its meetings.

Vaccine Disconnect

More than anything else MonkeyPox and COVID-19 have shown that we are interdependent, no matter what continent you call home.

Navigating the Future

Promising applications for targeted delivery may be cresting the horizon.

Process Development Struggles with Molecular Diversity

As we reach further afield in the molecular universe, we encounter new types of problems to resolve.

The Next Pandemic

Lions and tigers and monkeypox, oh my!

Dual Modality and New Analyses

Fresh insight is instrumental in the discussion of novel analytics.

Research Shows that Junk DNA Encodes Essential Immune and Metabolism Instructions

Researchers from the Telomere-to-Telomere Consortium have discovered new properties about junk DNA that could have wide-reaching implications.

Next Level Interrogation

3D cell cultures could provide key avenues to unlocking critical information.